[What emergencies arise from anticoagulant therapy?].
The antithrombotics (fibrinolytics, anticoagulants and aggregation inhibitors) belong to the most effective therapeutic methods and are used in all clinical specialties. The therapeutic mechanism of the fibrinolytics and anticoagulants is recognizable and can be regulated by hepatic parameters. Nevertheless, under this treatment patients undergo a potential risk of haemorrhage which not in every case can be estimated with the usual laboratory parameters. In addition to the factors increasing the potential risk false behaviour of the physician in charge and false behaviour on the side of the patient must be mentioned. In these two cases a treatment with antithrombotics should be omitted. If personal and technical insufficiencies are present the patient should be transferred to a centre for further treatment. In acute indications for discontinuing the treatment with antithrombotics depending on the clinical urgency a gradually different discontinuation by stages should be striven for, in order to avoid thromboembolic relapses.
D000925:Anticoagulants / Q000009:adverse effects*; D003911:Dextrans / Q000009:adverse effects; D003951:Diagnostic Errors; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006494:Heparin Antagonists; D006801:Humans; D011479:Protamines / Q000627:therapeutic use; D013300:Streptokinase / Q000037:antagonists & inhibitors; D013924:Thrombophlebitis / Q000175:diagnosis*; D014812:Vitamin K / Q000627:therapeutic use
D000925:Anticoagulants; D003911:Dextrans; D006494:Heparin Antagonists; D011479:Protamines; D014812:Vitamin K; D013300:Streptokinase
Welche notfallsituationen ergeben sich aus der therapie mit gerimmungshemmenden präparaten?